Targeted vascular drug delivery. A new day for an old way.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Panminerva Medica (Testo stampato)

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 24434344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty: Evidence From the Randomized PACIFIER Trial

  2012cited by this paper
• Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials

  2012cited by this paper
• Paclitaxel-Coated Versus Uncoated Balloon Angioplasty Reduces Target Lesion Revascularization in Patients With Femoropopliteal Arterial Disease: A Meta-Analysis of Randomized Trials

  2012cited by this paper
• Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.

  2011cited by this paper
• Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome.

  2011cited by this paper
• Catheter based local delivery of fluid paclitaxel: the Tübingen experience.

  2011cited by this paper
• First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome.

  2011cited by this paper
• From bench to Paccocath.

  2011cited by this paper
• Drug-coated balloons in peripheral arterial disease.

  2011cited by this paper
• Advances on drug-coated balloons.

  2010cited by this paper
• Optical coherence tomography after new scoring balloon angioplasty for in-stent restenosis and de novo coronary lesions.

  2010cited by this paper
• Drug-coated balloons for the prevention of vascular restenosis.

  2010cited by this paper
• Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model

  2009cited by this paper
• Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies

  2009cited by this paper
• Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.

  2009cited by this paper
• One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.

  2009cited by this paper
• Drug-eluting balloon: the comeback kid?

  2009cited by this paper
• Successful revascularization of re‐stenosis of lower extremity arteries with localized delivery of paclitaxel

  2008cited by this paper
• Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation

  2008cited by this paper
• Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

  2008cited by this paper
• Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter

  2008cited by this paper
• Catheter-based local antiproliferative therapy in kissing balloon technique for in-stent stenosis of coronary artery bifurcation lesions.

  2008cited by this paper
• Pathogenesis and local drug delivery for prevention of vascular access stenosis.

  2008cited by this paper
• Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial

  2008cited by this paper
• Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing

  2007cited by this paper
• Systemic Nanoparticle Paclitaxel (nab‐Paclitaxel) for In‐stent Restenosis I (SNAPIST‐I): A First‐in‐Human Safety and Dose‐finding Study

  2007cited by this paper
• Local paclitaxel delivery after coronary stenting in an experimental animal model

  2007cited by this paper
• Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

  2007cited by this paper
• A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

  2007cited by this paper
• Debating the risks of drug-eluting stents.

  2007cited by this paper
• Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

  2007cited by this paper
• Drug-eluting coronary stents--promise and uncertainty.

  2007cited by this paper
• Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.

  2006cited by this paper
• Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

  2006cited by this paper
• Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis

  2004cited by this paper
• Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model.

  2003cited by this paper
• Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation.

  2003cited by this paper
• Sirolimus for the prevention of in-stent restenosis in a coronary artery.

  2003cited by this paper
• Local delivery of paclitaxel using the double‐balloon perfusion catheter before stenting in the porcine coronary artery

  2001cited by this paper
• Local Intra-Arterial Drug Delivery for Prevention of Restenosis: Comparison of the Efficiency of Delivery of Different Radiopharmaceuticals Through a Porous Catheter

  2001cited by this paper
• Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo.

  2000cited by this paper
• Paclitaxel and arterial smooth muscle cell proliferation.

  1998cited by this paper
• A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.

  1998cited by this paper
• Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

  1997cited by this paper
• A physical measurement of the mechanisms of transluminal angioplasty.

  1984cited by this paper
• The mechanism of balloon angioplasty.

  1980cited by this paper

• No citing papers are available for this paper.